Anima Research receives investment from BNP Paribas Fortis Private Equity to support expansion of its industry-leading clinical trials business in Europe

Alken, Belgium – 3 December 2024: Anima Research (“Anima”), a leading European clinical trials center, today announces that it has received investment from BNP Paribas Fortis Private Equity, which will provide support for the Company as it expands its clinical trial operations in Europe. Anima is one of the most successful clinical trials centers in Europe, working across a range of therapeutic areas and significantly outperforming the industry average for patient recruitment and retention. Data show that ...